presentation © unconventional concepts inc.1 drug information association 2003 annual meeting...

Presentation © Unconventional Concepts Inc. 1

Drug Information Association2003 Annual Meeting

Counter-Terrorism SessionSan Antonio, Texas

June 17, 2003

Too Many Germs,Too Many Germs,Too Few MonkeysToo Few Monkeys

The Need for Artificial Organisms for The Need for Artificial Organisms for Testing and Validating PharmaceuticalsTesting and Validating Pharmaceuticals

Michael J. HopmeierChief,

Innovative and Unconventional Concepts

Unconventional Concepts, Inc.425 E. Hollywood Blvd, Suite AMary Esther, FL 32569(850) 243-4411, Fax (850) [email protected]


“Anthrax Letters”


Mediastinal Lymph Node:Microcolonies ofB. anthracis (Giemsa stain)

(www.phil.CDC.gov)

“Anthrax Letters”


Varying Presentations of Cutaneous Anthrax Lesions in New York City


Tularemia


Staphylococcal Ecthyma in HIV


Accidental Vaccinia


BubonicPlague


Plague History

• 200,000,000 deaths • Major Pandemics

- Plague of Justinian- “Black Death”- Modern Pandemic


Plague Epidemiology

Vector (flea) Bacteria block gut Feeding frenzy

Host (mammal) Rattus rattus (antiquity) Squirrels, cats, coyotes, bobcats


“The patient presents an image that fully justifies the horror and fright that

is associated with smallpox in the public’s

mind.” —William Osler

Smallpox


Crisis CenterThe lobby of Block E of Amoy Gardens was turned into a field headquarters for Hong Kong police and health officials after a SARS outbreak in the housing development.

Severe Acute Respiratory Syndrome (SARS)

Time Magazine, April 7, 2003


Coronavirus from SARS isolated in FRhK-4 cells. Thin section electron micrograph and negative stained virus particles

SARS Virus

Source: Department of Microbiology, The University of Hong Kong andthe Government Virus Unit, Department of Health, Hong Kong SAR China


African Green Monkey (Cercopithecus aethiops)

AKA vervet


Olive Baboon (Papio anubis)


Rhesus Macaque (Macaca mulatta)


Cynomolgus Macaque (Macaca fascicularis),AKA crab-eating or long-tailed macaque


Squirrel monkey (Saimiri sciureus)


Common Marmoset (Callithrix jacchus)

Cotton-Top Tamarin(Saguinas oedipus)


Northern Owl Monkey (Aotus trivirgatus)


World Medical AssociationDeclaration of Helsinki

June 1964 The Declaration of Geneva of the World Medical Assembly

binds the physician with the words, “The health of my patient will be my first consideration.”

“The purpose of biomedical research involving human subjects must be to improve diagnostic, therapeutic and prophylactic procedures and the understanding of the aetiology and pathogenesis of disease.”

Special caution must be exercised in the conduct of research which may affect the environment, and the welfare of animals used for research must be respected.

Biomedical research involving human subjects must conform to generally accepted scientific principles and should be based on adequately performed laboratory and animal experimentation and on a thorough knowledge of the scientific literature.


Animal Testing—Nuremberg Trials

“2. The experiment should be such as to yield fruitful results for the good of society, unprocurable by other methods or means of study, and not random and unnecessary in nature.

“3. The experiment should be so designed and based on the results of animal experimentation and a knowledge of the natural history of the disease or other problem under study that the anticipated results will justify the performance of the experiment.”

THE NUREMBERG CODE [from Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10.

Nuremberg, October 1946–April 1949. Washington, D.C.: U.S. G.P.O, 1949–1953.]


What—Exactly—Is the Problem?

• Shortage of acceptable animal models for testing of biological countermeasures– Availability at all

– Immunologically naïve

– Cost effective

– Efficacious

• Lack of facilities– Brick and mortar

– Personnel


Why Now?

• Anthrax and public awareness• New incentives

– Bioshield– Pharmaceutical stockpiles– Public demand for increased safety and efficacy– Multi-drug resistance– Greater susceptible populations

• MARKET PRESSURE!


Some Root Causes

• Rapidly expanding BW research is increasing demand– No-cure diseases mandating animal trials– Lots of federal money

• Purpose-raised supplies are being tapped out and are insufficient to meet needs

• Increased regulatory involvement and more rigorous controls

• China and India have greatly curtailed exports– SARS– Politics


Some Root Causes

• Aging infrastructure• Reduced funding to Primate Center System • Continued pressure on available primates for other research• FDA requirements on the pharmaceutical industry• Increasing pressure from eco-terrorists and animal rights groups

reducing participation from organizations• Human encroachment reducing environment and population sizes• Restrictions on exportation in countries of origin• Increasing difficulty in animal transportation

– Modes (commercial airlines, ground)– Regulatory issues (IATA)– Politics (Interim Guidelines, CDC; pressure on carriers)


Other Issues

• Biological sciences becoming more rigorous and demanding more control– Increasing need for “standardized” tests and subjects

– More subtle and sensitive techniques increasingly being used

– Science is becoming more “sensitive”

• Biology is moving from “art” to “science” and requires more rigorous “controls” on experiments


What We Need

• Ability to scale and adapt to changing volume and quantity demands

• Support ever more rigorous scientific challenges and research

• Provide efficacious data that can be validated for use in human models

• Meet the challenges of today and tomorrow


One Possible Path Forward

• Short Term (1–2 years)– Better and more effective utilization of current resources– Better coordination between public/private organizations

• Mid Term (3–10 years)– Rebuild “brick and mortar” infrastructure to modern standards and

predicted needs– Increase training and education to address shortfalls in skilled

personnel– Design and implement special-purpose breeding programs

• Long Term (10 years and out)– Enhanced tissue constructs


Short Term (1–2 Years)

• Identify and inventory existing stocks of NHPs

• Identify and inventory existing facilities– Breeding– Experimentation– Isolation– Transportation– Worldwide


Short Term (1–2 Years)

• Evaluate current and near-term requirements– Public and private

– Based on both national security and economic pressures

• Prioritize efforts within the U.S. government• Coordinate with industry (to the extent possible)• Maintain updated information for continuous

predictions


Mid-Term (3–10 Years)

• Design and construct “modern” facilities for breeding, housing and experimenting with NHPs

• Design and implement large-scale breeding programs to meet predicted needs

• Set aside colonies to meet demand during periods of national emergency or pandemics

• Centralize colonies and animal processing facilities, as well as specialized experimentation resources – Built around academic organizations– “Centers of Excellence”– Public/private venture


Mid-Term (3–10 Years)

• Personnel!– Significant Shortage of skilled technicians– Effects all levels of research

• Instrumentation design and manufacture

• Facility design and manufacture

• Experimental design and implementation

• Institute aggressive training and recruiting programs


Mid-Term (3–10 Years)Personnel• Alarming potential for large vacancy rate in laboratory positions

– Over the next 5 years, an estimated availability of 45,000 positions for clinical laboratory professionals (increased demand plus retirement/change of job)

– Only 20,000 lab graduates expected across the same time period; potential downfall of 25,000

– The current 12% vacancy rate in these positions compounds the deficit• Education and number of science students decreasing despite increasing

need – Educational programs for clinical laboratory scientists and technicians

dropped from 617 in 1995 to 480 in 2001– 10% decline in science-related bachelor’s degrees– Reduction in the number of foreign science graduates due to U.S. visa

restrictions and increasing incentives from their home countries


Long Term (10+ Years)

ALTERNATIVES TO ANIMAL MODELS• Models and Simulations

– Increase sophistication and efficacy– Develop new techniques for measurement and

diagnostics– Move from specific mechanisms to tissues to organs to

organisms– Develop agreed-on standards for creating and interfacing

models (similar to the Human Genome Project)

• Artificial systems


Long Term (10+ years)

• Artificial Systems– Artificial Grown Tissues

• Skin cultures• Cloning

– Artificial Organs– Artificial “organisms”

• Not necessarily actual organism, but sufficient for testing

• Possibly an “artificial immune system”


Long Term (10+ Years)

• DARPA Engineered Tissue Constructs Program

• Explores the technologies and science leading to the creation of a 3-D ex vivo human immune system.

• To be used for testing new vaccine constructs and immunomodulators that provide superior protection against threat agents.

• Brings together a combination of science and engineering communities


Summary

• The world has changed, and so must biomedical research

• We are going to hit major bottlenecks very soon in research

• Infrastructure and especially NHP research will become a major impediment soon

• We must be smarter in our use of our current resources

• We must find alternatives, not only to do better science, but also from an ethical standpoint

presentation © unconventional concepts inc.1 drug information association 2003 annual meeting...

Documents

department of health

conduct of research

hong kong police

university of hong kong

purpose of biomedical

health officials

human subjects

anticipated results